ETERNALS: Remote Monitoring in Lung Cancer Patients

Launched by ZIEKENHUIS OOST-LIMBURG · Jun 25, 2024

Keywords

ClinConnect Summary

The ETERNALS trial is looking at how well a remote monitoring system can work for patients with non-small cell lung cancer who are receiving chemotherapy. This study aims to see if using a mobile health system can help doctors keep track of patients' health while they are undergoing treatment, making it easier to provide care from a distance.

To participate in this trial, you need to be over 18 years old and have been diagnosed with Stage IV lung cancer, which is a more advanced form of the disease. It’s also important that you have a phone and can understand Dutch. Unfortunately, if your life expectancy is less than six weeks, you wouldn’t be eligible to join. If you take part in this trial, you can expect to use a remote monitoring system that will help your healthcare team stay informed about your health during your chemotherapy treatment. This could be an important step in improving care for lung cancer patients.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria:-
• • Patient must be in the possession of a phone
• • Diagnosis of Stage IV lung cancer patients treated with cytotoxic chemotherapy
• • Older than 18 years of age
• Exclusion Criteria:
• • Life expectancy of less than 6 weeks
• • Not able to understand the Dutch language